ResearcherTel Aviv UniversityNo recent work listed
Joon-Oh Park
Matched on OpenAlex author ID A5103514163. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 1
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2012: 1 paper · 2013: none · 2014: none · 2015: 1 trial · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper
Papers 3
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Co-author DOI 10.1056/nejmoa1903387↗
- Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. Co-author DOI 10.18632/oncotarget.17463↗
- Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/pmic.201200101↗
Trials 1
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Seok Heo · 2 shared papers, 2012–2017 · strength 0.08
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. DOI 10.1002/pmic.201200101↗
- Soo‐Youn Lee · 2 shared papers, 2012–2017 · strength 0.08
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. DOI 10.1002/pmic.201200101↗
- Young Suk Park · 2 shared papers, 2012–2017 · strength 0.08
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. DOI 10.1002/pmic.201200101↗
- Seong Ho Choi · 2 shared papers, 2012–2017 · strength 0.08
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. DOI 10.1002/pmic.201200101↗
- Hyung‐Doo Park · 2 shared papers, 2012–2017 · strength 0.08
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. DOI 10.1002/pmic.201200101↗
- Kwang Hyuck Lee · 2 shared papers, 2012–2017 · strength 0.08
- Paper Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach. DOI 10.18632/oncotarget.17463↗
- Paper Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. DOI 10.1002/pmic.201200101↗
- Daniel Hochhauser · 1 shared paper, 2019 · strength 0.07
- Talia Golan · 1 shared paper, 2019 · strength 0.07
- Eileen Mary O'Reilly · 1 shared paper, 2019 · strength 0.07
- Do‐Youn Oh · 1 shared paper, 2019 · strength 0.07
- Dirk Arnold · 1 shared paper, 2019 · strength 0.07
- Michael J. Hall · 1 shared paper, 2019 · strength 0.07
- Giampaolo Tortora · 1 shared paper, 2019 · strength 0.07
- Anke Reinacher‐Schick · 1 shared paper, 2019 · strength 0.07
- Hedy Lee Kindler · 1 shared paper, 2019 · strength 0.07
- Michele Reni · 1 shared paper, 2019 · strength 0.07
- Pascal R. Hammel · 1 shared paper, 2019 · strength 0.07
- Hana Algül · 1 shared paper, 2019 · strength 0.07
- Eric Van Cutsem · 1 shared paper, 2019 · strength 0.07
- Teresa Mercade Macarulla · 1 shared paper, 2019 · strength 0.07
- Kee‐Taek Jang · 1 shared paper, 2017 · strength 0.06
- Dong Wook Choi · 1 shared paper, 2017 · strength 0.06
- Jong Kyun Lee · 1 shared paper, 2017 · strength 0.06
- Jisook Park · 1 shared paper, 2017 · strength 0.06
- Eunjung Lee · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.